STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
71 hedge funds and large institutions have $131M invested in Stemline Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $166M → $131M (-$35.6M)
Holders
71
Holding in Top 10
–
Calls
$384K
Puts
$53K
Top Buyers
| 1 | +$2.79M | |
| 2 | +$989K | |
| 3 | +$778K | |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$444K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$384K |
Top Sellers
| 1 | -$6.87M | |
| 2 | -$2.03M | |
| 3 | -$1.53M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.23M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.17M |